Ticker | VRT | Earnings Date | July 29, 2026 (11:00 AM ET) |
Exchange | NYSE | Prepared | July 28, 2026 |
Reporting Period | Q2 2026 (ended June 30, 2026) | Last Close | $287.60 (July 27, 2026) |
Sources: Visible Alpha consensus and actuals data. Q2 2026 guidance from VRT Q1 2026 earnings release (April 22, 2026). Note: Q1 2026 FCF actual taken from company-reported earnings release; VA has not yet ingested this period.
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Adj. EPS | $1.17 | $1.01 | +15.8% | Beat |
Q1 2026 | Net Sales | $2.65B | $2.65B | 0.0% | In-Line |
Q4 2025 | Adj. EPS | $1.36 | $1.29 | +5.4% | Beat |
Q4 2025 | Net Sales | $2.88B | $2.88B | 0.0% | In-Line |
Q3 2025 | Adj. EPS | $1.24 | $0.99 | +25.3% | Beat |
Q3 2025 | Net Sales | $2.68B | $2.59B | +3.5% | Beat |
Q2 2025 | Adj. EPS | $0.95 | $0.84 | +13.1% | Beat |
Q2 2025 | Net Sales | $2.64B | $2.36B | +11.9% | Beat |
Q1 2025 | Adj. EPS | $0.64 | $0.62 | +3.2% | Beat |
Q1 2025 | Net Sales | $2.04B | $1.94B | +5.2% | Beat |
Q4 2024 | Adj. EPS | $0.99 | $0.82 | +20.7% | Beat |
Q4 2024 | Net Sales | $2.35B | $2.16B | +8.8% | Beat |
Q3 2024 | Adj. EPS | $0.76 | $0.69 | +10.1% | Beat |
Q3 2024 | Net Sales | $2.07B | $1.98B | +4.8% | Beat |
Q2 2024 | Adj. EPS | $0.67 | $0.57 | +17.5% | Beat |
Q2 2024 | Net Sales | $1.95B | $1.94B | +0.7% | Beat |
VRT has beaten adjusted EPS consensus in each of the last 8 quarters, with an average surprise of approximately +14% — a consistent pattern that sets a high bar for the market's implicit expectations even when the stated consensus appears achievable.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Full-year guidance was raised meaningfully at Q1 earnings (April 22) and has not been formally revised since. The May Investor Conference reaffirmed the long-term algorithm with upgraded 5-year targets but left 2026 guidance unchanged. Tone has shifted from cautious tariff management to confident mitigation.
Metric | Initial Guidance (Q1 2026 Earnings, Apr 22) | Revised Guidance | Current Consensus | Note |
Q2 2026 Net Sales | $3.25B–$3.45B | — | $3.39B | Unchanged since Q1 print; consensus at midpoint |
Q2 2026 Adj. Op. Margin | 20.7%–21.7% | — | 21.5% | Consensus slightly above midpoint (21.2%); Q1 came in 180bps above guidance |
Q2 2026 Adj. Diluted EPS | $1.37–$1.43 | — | $1.44 | Consensus slightly above high end of range; reflects pattern of consistent beats |
FY 2026 Net Sales | $13.5B–$14.0B (30% organic growth) | — | $13.89B | Raised at Q1 from prior guide; May Investor Conference left unchanged |
FY 2026 Adj. Op. Margin | 22.8%–23.8% (23.3% mid) | — | 23.4% | Raised 80bps at Q1; May conference reaffirmed; consensus at midpoint |
FY 2026 Adj. Diluted EPS | $6.30–$6.40 (+51% YoY) | — | $6.48 | ↑ Raised $0.33 at Q1 earnings; consensus slightly above high end, consistent with beat pattern |
FY 2026 Adj. Free Cash Flow | $2.1B–$2.3B (+17% YoY) | — | $2.27B | Maintained at Q1; consensus at midpoint |
EMEA Organic Growth (FY) | Flat YoY | — | N/A (not separately tracked in VA) | H2 return to YoY growth embedded in guidance; Q1 EMEA was −29% organic |
Long-Term Revenue CAGR (5-yr) | Low-to-mid teens (2024 Investor Day) | 20–22% CAGR | N/A | ↑ Raised at May 19–20 Investor Conference; TAM expanded to ~$75B |
Long-Term Adj. Op. Margin Target | 25% (2024 Investor Day) | 27% | N/A | ↑ Raised at May 19–20 Investor Conference |
Sources: VRT Q1 2026 Earnings Release and Transcript (April 22, 2026); Vertiv Investor Conference transcripts (May 19–20, 2026); Visible Alpha Consensus Data.
Key Takeaway: Estimates have moved higher since Q1 earnings across all key metrics, tracking with the raised guidance. The EPS revision trajectory is particularly notable — consensus has risen from ~$1.25 post-Q4 to $1.44 today for Q2, and from ~$6.47 to $6.48 for the full year, suggesting the street has largely absorbed the guidance raise with modest additional upward drift.
KPI (Period) | Estimate ~Apr 29, 2026 (Post-Q1 Baseline) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Cons. vs. Guidance Mid |
Net Sales — Q2 2026 | $3.38B | $3.39B | +0.3% | $3.25B–$3.45B | Unchanged | — | +0.3% vs. $3.35B mid |
Adj. Op. Margin — Q2 2026 | 21.4% | 21.5% | +10bps | 20.7%–21.7% | Unchanged | — | +30bps vs. 21.2% mid |
Adj. EPS — Q2 2026 | $1.43 | $1.44 | +0.7% | $1.37–$1.43 | Unchanged | — | +2.8% vs. $1.40 mid |
Net Sales — FY 2026 | $13.88B | $13.89B | +0.1% | $13.5B–$14.0B | Unchanged | — | +1.0% vs. $13.75B mid |
Adj. Op. Margin — FY 2026 | 23.4% | 23.4% | Flat | 22.8%–23.8% | Unchanged | — | +10bps vs. 23.3% mid |
Adj. EPS — FY 2026 | $6.47 | $6.48 | +0.2% | $6.30–$6.40 | Unchanged | — | +1.2% vs. $6.35 mid |
Free Cash Flow — FY 2026 | $2.27B | $2.27B | Flat | $2.1B–$2.3B | Unchanged | — | At midpoint |
Estimates have been remarkably stable since the Q1 print, with consensus tracking guidance midpoints closely. The slight premium of consensus to guidance midpoints on EPS reflects the market's expectation of continued operational outperformance, consistent with VRT's 8-quarter beat streak.
Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline uses consensus as of approximately April 29, 2026 (5 trading days post-earnings).
Key Takeaway: No open-market buys or discretionary sells were identified in the post-Q1 period (April 22 – July 28, 2026). All Form 4 filings reviewed consisted exclusively of non-discretionary transactions: RSU/DSU vesting-related tax withholding (Code F), dividend-equivalent DSU accruals (Code A), and 401(k) plan acquisitions. The absence of open-market activity is neither a positive nor negative signal — it is consistent with a company in a quiet period ahead of earnings and with insiders whose equity compensation is primarily RSU-based.
Name | Title | Transaction Type | Value | Date | Note |
Multiple Insiders | Various | RSU/DSU Tax Withholding (Code F) | Various | Apr–Jul 2026 | Mandatory tax withholding upon RSU/DSU vesting; not discretionary |
Multiple Insiders | Various | DSU Dividend Accrual (Code A) | Various | Apr–Jul 2026 | Automatic accrual of dividend-equivalent DSUs on RSUs; non-discretionary |
Multiple Insiders | Various | 401(k) Plan Acquisition | Various | Apr–Jul 2026 | Shares acquired under 401(k) plan; exempt from reporting requirements |
No open-market purchases (Code P), open-market sales (Code S), or 10b5-1 plan initiations were identified in the review period. Source: SEC Form 4 filings reviewed via SEC EDGAR (April 22 – July 28, 2026).